• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Caval thrombolysis in neonates using low doses of recombinant human tissue-type plasminogen activator.

作者信息

Anderson B J, Keeley S R, Johnson N D

机构信息

Department of Intensive Care, Royal Children's Hospital, Melbourne, Victoria, Australia.

出版信息

Anaesth Intensive Care. 1991 Feb;19(1):22-7. doi: 10.1177/0310057X9101900104.

DOI:10.1177/0310057X9101900104
PMID:1901463
Abstract

Four neonates suffered caval thrombosis secondary to indwelling central catheters. Dissolution of thrombus with recombinant tissue plasminogen activator (rt-PA) as a low-dose infusion (0.05 mg/kg/hr) directly into thrombus was successful in three patients. rt-PA was ceased after three days in the fourth patient because of catheter malposition. Thrombolysis was achieved between four and ten days. Rethrombosis occurred in one patient despite heparin prophylaxis. Plasminogen activator infusions were titrated to maintain fibrinogen levels above 100 mg/dl. One neonate suffered an intracranial haemorrhage. Regional rt-PA is an alternative to thrombectomy in critically ill neonates.

摘要

相似文献

1
Caval thrombolysis in neonates using low doses of recombinant human tissue-type plasminogen activator.
Anaesth Intensive Care. 1991 Feb;19(1):22-7. doi: 10.1177/0310057X9101900104.
2
Recombinant tissue plasminogen activator for neonatal and pediatric vascular thrombolytic therapy.重组组织型纤溶酶原激活剂用于新生儿和儿童血管溶栓治疗。
J Pediatr Surg. 1993 Oct;28(10):1264-8; discussion 1268-9. doi: 10.1016/s0022-3468(05)80310-0.
3
Thrombolytic therapy in preterm infants: Fifteen-year experience.早产儿溶栓治疗:15 年经验。
Pediatr Blood Cancer. 2020 Oct;67(10):e28544. doi: 10.1002/pbc.28544. Epub 2020 Jul 25.
4
Thrombolysis with low dose tissue plasminogen activator.低剂量组织型纤溶酶原激活剂溶栓治疗
Arch Dis Child. 1992 Dec;67(12):1483-4. doi: 10.1136/adc.67.12.1483.
5
[Thrombosis of the iliac artery in a premature neonate: thrombolytic therapy using rt-PA].[早产新生儿髂动脉血栓形成:使用重组组织型纤溶酶原激活剂进行溶栓治疗]
Z Geburtshilfe Neonatol. 2004 Feb;208(1):36-41. doi: 10.1055/s-2004-815522.
6
[Successful lysis of a septic thrombosis of the superior vena cava using recombinant tissue-plasminogen activator].
Klin Padiatr. 1991 Sep-Oct;203(5):363-5. doi: 10.1055/s-2007-1025454.
7
[Thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in 13 children: a case series].13例儿童重组组织型纤溶酶原激活剂(rt-PA)溶栓治疗:病例系列
Wien Klin Wochenschr. 2000 Nov 10;112(21):927-33.
8
Use of tissue type plasminogen activator in neonates: case reports and review of the literature.组织型纤溶酶原激活剂在新生儿中的应用:病例报告及文献综述
Am J Perinatol. 1996 May;13(4):217-22. doi: 10.1055/s-2007-994367.
9
Catheter-directed thrombolysis of inferior vena cava thrombosis in a 13-day-old neonate and review of literature.13日龄新生儿下腔静脉血栓形成的导管定向溶栓治疗及文献复习
Cardiovasc Intervent Radiol. 2008 Jul;31 Suppl 2:S153-60. doi: 10.1007/s00270-007-9229-9. Epub 2007 Nov 15.
10
Successful use of tissue plasminogen activator in catheter-related intracardiac thrombus of a premature infant.组织型纤溶酶原激活剂成功用于早产儿导管相关的心内血栓。
Am J Perinatol. 2003 Feb;20(2):91-6. doi: 10.1055/s-2003-38343.

引用本文的文献

1
Clinical experience with alteplase in the management of intracardiac and major cardiac vessels thrombosis in pediatrics: a case series.阿替普酶治疗小儿心内及主要心脏血管血栓形成的临床经验:病例系列
Ann Saudi Med. 2010 May-Jun;30(3):227-32. doi: 10.4103/0256-4947.62840.
2
Thrombosis in the critically ill neonate: incidence, diagnosis, and management.危重新生儿的血栓形成:发病率、诊断与管理
Vasc Health Risk Manag. 2008;4(6):1337-48. doi: 10.2147/vhrm.s4274.
3
Thrombolytic agents for arterial and venous thromboses in neonates.用于新生儿动脉和静脉血栓形成的溶栓剂。
Cochrane Database Syst Rev. 2005 Jan 25;2005(1):CD004342. doi: 10.1002/14651858.CD004342.pub2.
4
Successful treatment of superior vena cava thrombosis in a neonate.
Eur J Pediatr. 2002 Aug;161(8):466-7. doi: 10.1007/s00431-002-0992-y.
5
Management of preterm infants with intracardiac thrombi: use of thrombolytic agents.患有心内血栓的早产儿的管理:溶栓剂的使用。
Paediatr Drugs. 2001;3(12):883-98. doi: 10.2165/00128072-200103120-00002.
6
Treatment of neonatal thrombus formation with recombinant tissue plasminogen activator: six years experience and review of the literature.重组组织型纤溶酶原激活剂治疗新生儿血栓形成:六年经验及文献综述
Arch Dis Child Fetal Neonatal Ed. 2001 Jul;85(1):F18-22. doi: 10.1136/fn.85.1.f18.
7
Pediatric interventional radiology: current practice and innovations.儿科介入放射学:当前实践与创新
Cardiovasc Intervent Radiol. 1993 Sep-Oct;16(5):267-74. doi: 10.1007/BF02629156.
8
Tissue plasminogen activator (alteplase) treatment for femoral artery thrombosis after cardiac catheterisation in infants and children.组织型纤溶酶原激活剂(阿替普酶)治疗婴幼儿和儿童心导管插入术后股动脉血栓形成
Br Heart J. 1993 Oct;70(4):382-5. doi: 10.1136/hrt.70.4.382.
9
Pulse-spray thrombolysis of inferior vena cava thrombosis complicating filter placement.
Cardiovasc Intervent Radiol. 1994 Jan-Feb;17(1):38-40. doi: 10.1007/BF01102071.
10
Thrombolysis with low dose tissue plasminogen activator.低剂量组织型纤溶酶原激活剂溶栓治疗
Arch Dis Child. 1992 Dec;67(12):1483-4. doi: 10.1136/adc.67.12.1483.